Workday Expands AI Reach With Solopreneur Program As Shares Trade Lower

  • Workday (NasdaqGS:WDAY) has launched an AI-powered Foundation Solopreneurship Accelerator Program in the U.S.
  • The program, created with Anthropic and the Local Initiatives Support Corporation, targets solo entrepreneurs with grants, AI credits, and business coaching.
  • This is Workday's first major AI initiative focused on small businesses rather than its traditional enterprise customer base.

Workday enters this new effort with its stock trading at $128.14 and a return over the past week of 2.5%. Over longer periods, the shares have faced pressure, with the stock down 37.7% year to date and down 46.2% over the past year. Against that backdrop, investors watching NasdaqGS:WDAY may view this move as part of the company broadening how its AI capabilities are used and perceived.

For readers, the key angle is how this program might expand Workday's ecosystem into the solo and very small business segment while reinforcing its AI credentials. The impact will depend on how many entrepreneurs actually use the tools, how effectively they apply AI in their operations, and whether this effort eventually connects back to Workday's core products and customer relationships.

Stay updated on the most important news stories for Workday by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Workday.

NasdaqGS:WDAY Earnings & Revenue Growth as at May 2026
NasdaqGS:WDAY Earnings & Revenue Growth as at May 2026

We've flagged 0 risks for Workday. See which could impact your investment.

Advertisement

Quick Assessment

  • ✅ Price vs Analyst Target: At US$128.14, the stock trades about 27% below the US$175.16 analyst price target range midpoint.
  • ✅ Simply Wall St Valuation: The shares are flagged as undervalued, trading 59.2% below the platform's estimated fair value.
  • ✅ Recent Momentum: The 30 day return is a positive 1.2%, which is modest but moving in the right direction.

There is only one way to know the right time to buy, sell or hold Workday. Head to Simply Wall St's company report for the latest analysis of Workday's Fair Value.

Key Considerations

  • 📊 The Solopreneurship Accelerator Program may help widen Workday's brand reach into small businesses while showcasing its AI capabilities with Anthropic.
  • 📊 Watch uptake of the grants, AI credits and coaching, and whether this eventually feeds into usage of Workday's paid software products.
  • ⚠️ With no flagged risks in the current dataset, the main unknown here is execution, including program scale, costs and measurable outcomes for participants.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Workday analysis. Alternatively, you can visit the community page for Workday to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Workday might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:WDAY

Workday

Provides enterprise cloud applications in the United States and internationally.

Flawless balance sheet with solid track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
51 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4849.2% undervalued
204 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43038.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9956.4% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

ON
LOT logo
Ontological on Lotus Technology ·

Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization

Fair Value:US$2.463.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NE
AIIO logo
newsfinder11221 on Robo.ai ·

Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution

Fair Value:US$540.4% undervalued
1 users have followed this narrative
2 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
ALMIN logo
European_Hidden_Gem_Stocks on MINT Société anonyme ·

Mint SA: A French Micro-Cap Energy Retailer Worth Watching

Fair Value:€1153.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
87 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
196 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0